Sonya Branco
Analyst · that Q&A period, we'll open the call to questions from members of the media. Let me now turn the call over to Marc
Thank you, Marc, and good afternoon, everyone. Consolidated revenue for the first quarter was $825.6 million, up 14% compared to $722 million in the first quarter of last year. And segment operating income, before specific items, was $113.3 million, up 15% from $98.5 million last year. Quarterly net income before specific items was $63.2 million or $0.24 per share, which is 8% lower than the $0.26 we've recorded in the first quarter last year. Net finance expense for the first quarter was $34.9 million, up from $16 million in the first quarter of fiscal 2019. We had higher interest resulting from the long-term debt we issued at the end of last year to fund the acquisition of the Bombardier BAT business as well as we had a higher interest on these liabilities because of the adoption of IFRS 16. Income taxes this quarter were $13 million, representing an effective tax rate of 17%, which is up from 13% for the first quarter last year. The higher tax rate was mainly due to the impact of tax audits in Canada last year, partially offset by a change in the mix of income from various jurisdictions. Cash provided by operating activities this quarter was up 18% to $137.8 million compared to $117.2 million in the first quarter of fiscal 2019. Free cash flow was negative $102 million in the quarter compared to negative $86 million last year. We had higher investments related to work-in-progress inventory for simulator products to be delivered over the balance of the year, and we had lower payables. We usually see a higher investment in noncash working capital accounts in the first half of the year. And as in previous years, we expect a portion of the noncash working capital investment to reverse in the second half. Uses of cash in Q1 included funding capital expenditures for $89 million, mainly for growth and specifically to add capacity to our global training network to deliver on the long-term exclusive training contracts in our backlog. We continue to expect total capital expenditures for the year to be modestly higher than the prior by about 10% to 15%. Other uses of cash included the distribution of $25.5 million in cash dividends, and we used another $2 million to repurchase stock at a weighted average price of $34.41 per common share under the NCIB program. Our financial position continued to be solid, with a net debt of $2.3 billion at the end of the quarter, for a net debt-to-total-capital ratio of 49.4%. This reflects the issuance of the unsecured senior notes for the Bombardier BAT business acquisition and the higher usage of cash to fund working capital in the first half of the year. Since we adopted IFRS 16, effective April 1, 2019, net debt now also includes obligations under lease contracts, which were previously accounted for as operating leases and therefore not included in debt. Excluding this impact, the net debt-to-capital ratio would have been 46.3% this quarter. Return on capital employed before specific items, and excluding the impacts of IFRS 16, was 12% this quarter, a bit lower than the 12.6% last year. As we ramp up the large Bombardier BAT business acquisition, we continue to target 13% return on capital employed by fiscal 2022. Now looking at our segment performance. In Civil, first quarter revenue was up 11% year-over-year to $477.6 million and operating income before specific items was up 29% to $101 million for a margin of 21.1%. From a mixed standpoint, simulator product deliveries were lower compared to the first quarter last year as we expected, while training services growth was especially strong with our expanded capacity. On the order front, Civil book-to-sales ratio for the quarter was 1.4x and for the trailing 12 months was 1.54x. In Defence, first quarter revenue of $320.5 million was up 19% over Q1 of last year, while operating income was down 30% to $15.1 million, for an operating margin of 4.7%. In Defence, product margins are typically higher than services, and the strong revenue growth in the first quarter was skewed to nearly 2/3 services and I'd add, mainly on new awarded service programs during the early stages of profitability ramp-up. The lower segment operating income in the first quarter reflects this mix as well as the second-half-weighted timing of product program milestones we plan to achieve on the higher-margin product contract already in our backlog. The mix and balance in the quarter also reflects some variability in the timing of new product orders we expect to conclude during the course of the year. The Defence book-to-sales ratio was 0.68x for the quarter and 0.83x for the last 12 months. Lastly, in Healthcare, we continue to ramp up scale, with a first quarter revenue of $27.5 million, which is 21% higher than the $22.8 million in Q1 of last year. Healthcare segment operating loss was $2.8 million in the quarter compared to a loss of $1.3 million in Q1 of last year, mainly because of higher investment in SG&A to support a larger business. With that, I will ask Marc to discuss the way forward.